Actively Recruiting
Influence of Radiotherapy and Chemotherapy in the Value of Peripheral Blood Lymphocyte Subsets Among Thoracic Cancer
Led by Shanghai Cancer Hospital, China · Updated on 2020-08-21
500
Participants Needed
1
Research Sites
778 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is an observation, single center study to evaluate the alternations and prognostic value of peripheral blood lymphocyte (PBL) in patients diagnosed with thoracic cancers, including lung cancer, esophageal squamous cell carcinoma and thymic epithelial carcinoma underwent radiotherapy with or without chemotherapy.
CONDITIONS
Official Title
Influence of Radiotherapy and Chemotherapy in the Value of Peripheral Blood Lymphocyte Subsets Among Thoracic Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- At least 18 years old
- ECOG performance status 0-1
- Pathologically confirmed non-small cell lung cancer, esophageal squamous cell carcinoma, or thymic epithelial tumor
- Life expectancy longer than 3 months
- No indication for palliative radiotherapy as judged by the investigator
- Prior surgery allowed if fully recovered from surgery-related toxicity or complications
- Signed consent to provide fresh tumor biopsies before and during treatment
- Women of childbearing age and men agree to use effective contraception during the trial
- Adequate organ function within 1 week before enrollment, including bone marrow, liver, and kidney function
You will not qualify if you...
- Pregnant or breastfeeding women
- History of any other cancer
- Patients needing palliative radiotherapy as judged by the investigator
- Active infection
- Congestive heart failure, heart attack within 6 months, unstable angina, or cardiac arrhythmia
- Received tumor vaccine or live attenuated vaccine within 4 weeks before treatment
- Mental disorders, drug abuse, or social conditions that may affect study compliance
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China, 200032
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here